Stock listing

OTC:ERGO Entia Biosciences Inc Stock

Follow Entia Biosciences Inc into a list and get an email when it puts out news.

Share price · OTC:ERGO

$0.0002 USD 0.0000 (0.0%)

Close on Oct 13, 2026 · Data provided by Twelve Data

Ticker: OTC:ERGO
Asset type: Stock
Exchange: OTC
Currency: USD

Latest news

Entia Biosciences, Inc. (OTCQB: ERGO) Enters into Exclusive Worldwide Licensing Agreement for its GROH Beauty Products Line

Feb 24, 2017

Entia Biosciences, Inc. (OTCQB: ERGO) Receives Notification of the Grant of European Patent it has Exclusively Licensed for Identifying the Ergothioneine Transporter and its Therapeutic Uses

Nov 2, 2016

Entia Biosciences, Inc. (OTCQB: ERGO) to Present Results of Chronic Kidney Disease Medical Food Clinical Study at American Society of Nephrology / Kidney Week 2016 Annual Meeting

Oct 6, 2016

Preliminary clinical results for Entia Biosciences, Inc.’s new, proprietary ErgoD2® medical food show an average increase in kidney filtration rate of approximately 10% for over 75% of test subjects, after only three months

Sep 26, 2016

UPDATE -- Entia Biosciences, Inc. Begins Clinical Study of Proprietary ErgoD2® Medical Food Product to Demonstrate Improved Health for the More Than 25 Million Chronic Kidney Disease Sufferers in the U.S.

Dec 21, 2015

Ergomed Increases Its Co-Development Contribution up to $12,000,000 in CEL-SCI’s Phase 3 Head and Neck Cancer Trial

Oct 5, 2015

Issued by another party

OTC Markets Group Welcomes Newly Verified OTCQB Companies – May 18

May 18, 2015

All Entia Biosciences Inc news

Entia Biosciences Inc on 6ix

News releases: 8 in all · newest Feb 24, 2017 · oldest 2015

Log in to ask 6ix AI your own questions about Entia Biosciences Inc.